Eli Lilly and Company vs Pfizer, Inc. — Stock Comparison
Eli Lilly and Company (LLY) and Pfizer, Inc. (PFE) are both listed on US exchanges. This page compares their Q·Score ratings, key fundamentals (P/E, margins, growth), and Wall Street analyst consensus side by side. Data sourced from Yahoo Finance and updated on each page load.
Eli Lilly and Company clearly outscores Pfizer, Inc. on Q·Score (7.7 vs 6.1 out of 10), led by Growth (9.8 vs 5.9) and Quality (9 vs 5.4). Pfizer, Inc. scores higher on Health, reflecting stronger balance sheet strength. Analyst consensus targets imply greater upside for LLY (+9.4%) than for PFE (+7.0%).
Price Performance
Normalised to 100 at period start — shows relative performance.
Q·Score Breakdown
Earnings growing 26% year-over-year on 48% revenue growth.
Consistently beats earnings estimates (4/4 quarters).
⚠ analyst sentiment is cautious.
Analyst Consensus
Fundamentals
Frequently Asked Questions
LLY vs PFE: which stock scores better overall?
Based on Q·Score, Eli Lilly and Company (LLY) scores 7.7/10 versus Pfizer, Inc. (PFE) at 6.1/10. The Q·Score measures five dimensions: Quality, Health, Growth, Valuation, and Sentiment. For informational purposes only — not financial advice.
Which has better revenue growth: LLY or PFE?
Eli Lilly and Company (LLY) scores higher on Growth (9.8/10 vs 5.9/10). Eli Lilly and Company reports revenue growth (47.7% YoY) while Pfizer, Inc. reports (2.6% YoY). Growth scores reflect revenue and earnings momentum relative to sector peers.
Is LLY or PFE more attractively valued?
Pfizer, Inc. (PFE) scores higher on Valuation (6.7/10 vs 6.3/10). LLY trades at 25.7× P/E versus PFE at 9.3×. Valuation is assessed using P/E ratio, analyst price targets, and 52-week range positioning relative to sector peers.
What do analysts say about LLY vs PFE?
There are 26 analysts covering LLY with a consensus price target of $1297.31, and 26 analysts covering PFE with a consensus target of $28.63. Analyst consensus ratings are aggregated from Wall Street research and do not constitute investment advice.
Which is more profitable: LLY or PFE?
Eli Lilly and Company (LLY) scores higher on Quality (9/10 vs 5.4/10). Net profit margin: LLY at 33.5%, PFE at 6.8%. Quality scores reflect profit margins, return on equity, and free cash flow generation.
Which has stronger financial health: LLY or PFE?
Pfizer, Inc. (PFE) scores higher on Financial Health (7/10 vs 5.5/10). Market beta: LLY at 0.51, PFE at 0.28. Health scores consider beta, debt-to-equity, and current ratio. All investments carry risk — this is not investment advice.
What are the market caps of LLY and PFE?
Eli Lilly and Company (LLY) has a market capitalisation of $1.06T, while Pfizer, Inc. (PFE) has a market cap of $152.5B. Market cap data is sourced from Yahoo Finance and reflects the most recent available figures.
Do LLY or PFE pay dividends?
LLY pays a dividend yield of 0.58%, while PFE pays a dividend yield of 6.56%. Dividend yields fluctuate with share price and company payout decisions.
Related Comparisons
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →